GLP-1 drugs , or glucagon-like peptide-1 compounds, represent a truly development in how we approach type 2 diabetes . These new therapies work by mimicking the body’s own GLP-1 substance , which https://socialicus.com/story7252523/glp-1-a-major-breakthrough-in-diabetes-treatment